Cite
Cyclophosphamide-based stem cell mobilization in relapsed multiple myeloma patients: A subgroup analysis from the phase III trial Re LApsE.
MLA
Baertsch, Marc‐Andrea, et al. “Cyclophosphamide-Based Stem Cell Mobilization in Relapsed Multiple Myeloma Patients: A Subgroup Analysis from the Phase III Trial Re LApsE.” European Journal of Haematology, vol. 99, no. 1, July 2017, pp. 42–50. EBSCOhost, https://doi.org/10.1111/ejh.12888.
APA
Baertsch, M., Schlenzka, J., Lisenko, K., Krzykalla, J., Becker, N., Weisel, K., Noppeney, R., Martin, H., Lindemann, H. W., Haenel, M., Nogai, A., Scheid, C., Salwender, H., Fenk, R., Graeven, U., Reimer, P., Schmidt, H. M., Goerner, M., Schmidt, W. I. G. H., & Klein, S. (2017). Cyclophosphamide-based stem cell mobilization in relapsed multiple myeloma patients: A subgroup analysis from the phase III trial Re LApsE. European Journal of Haematology, 99(1), 42–50. https://doi.org/10.1111/ejh.12888
Chicago
Baertsch, Marc‐Andrea, Jana Schlenzka, Katharina Lisenko, Julia Krzykalla, Natalia Becker, Katja Weisel, Richard Noppeney, et al. 2017. “Cyclophosphamide-Based Stem Cell Mobilization in Relapsed Multiple Myeloma Patients: A Subgroup Analysis from the Phase III Trial Re LApsE.” European Journal of Haematology 99 (1): 42–50. doi:10.1111/ejh.12888.